Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Marine OXYgen Carrier: HEMO2Life® for hypOthermic Kidney Graft Preservation, Before Transplantation

NCT02652520 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT02652520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02652520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Marine OXYgen Carrier: HEMO2Life® for hypOthermic Kidney Graft Preservation, Before Transplantation
Lead sponsor
University Hospital, Brest
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2016
Completion date
February 23, 2018
Enrollment
60 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal diseases